CHRN saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 77 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CHRN turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 42 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CHRN moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for CHRN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CHRN's RSI Oscillator exited the oversold zone, 29 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 61 cases where CHRN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
Following a +11.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRN advanced for three days, in 241 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
CHRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CHRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.026) is normal, around the industry mean (2.669). P/E Ratio (0.000) is within average values for comparable stocks, (16.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (36.101) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where GLE advanced for three days, in 90 of 101 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
GLE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLE as a result. In 41 of 41 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for GLE turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 19 similar instances when the indicator turned negative. In 18 of the 19 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
GLE moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for GLE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GLE entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. GLE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.391) is normal, around the industry mean (2.669). GLE has a moderately high P/E Ratio (140.184) as compared to the industry average of (16.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.112) among similar stocks. P/S Ratio (8.425) is also within normal values, averaging (139.965).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
CHRN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 38 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CHRN | GLE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| Advances ODDS (%) | 2 days ago 84% | 8 days ago 89% |
| Declines ODDS (%) | 4 days ago 85% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHRN’s FA Score shows that 0 FA rating(s) are green while GLE’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHRN’s TA Score shows that 4 TA indicator(s) are bullish while GLE’s TA Score has 4 bullish TA indicator(s).
CHRN (@Information Technology Services) experienced а -3.68% price change this week, while GLE (@Information Technology Services) price change was -34.65% for the same time period.
The average weekly price growth across all stocks in the @Information Technology Services industry was -1.89%. For the same industry, the average monthly price growth was -5.13%, and the average quarterly price growth was -7.47%.
The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.
A.I.dvisor tells us that CHRN and KEEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHRN and KEEL's prices will move in lockstep.
| Ticker / NAME | Correlation To CHRN | 1D Price Change % | ||
|---|---|---|---|---|
| CHRN | 100% | -6.98% | ||
| KEEL - CHRN | 29% Poorly correlated | -6.67% | ||
| WYY - CHRN | 27% Poorly correlated | +3.34% | ||
| CIFR - CHRN | 27% Poorly correlated | -8.87% | ||
| PENG - CHRN | 25% Poorly correlated | -11.08% | ||
| APLD - CHRN | 24% Poorly correlated | -9.01% | ||
More | ||||
A.I.dvisor tells us that GLE and IBEX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLE and IBEX's prices will move in lockstep.
| Ticker / NAME | Correlation To GLE | 1D Price Change % | ||
|---|---|---|---|---|
| GLE | 100% | -5.10% | ||
| IBEX - GLE | 24% Poorly correlated | +0.06% | ||
| DAIC - GLE | 19% Poorly correlated | -9.68% | ||
| AUR - GLE | 17% Poorly correlated | -2.99% | ||
| CHRN - GLE | 16% Poorly correlated | -6.98% | ||
| PONY - GLE | 15% Poorly correlated | -0.40% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PSMR | 33.03 | N/A | N/A |
| Pacer Swan SOS Moderate (April) ETF (PSMR) | |||
| FYC | 113.35 | -1.23 | -1.07% |
| First Trust Small Cap Growth AlphaDEX Fund (FYC) | |||
| UAE | 19.27 | -0.45 | -2.28% |
| iShares MSCI UAE ETF (UAE) | |||
| SMU | 7.02 | -0.34 | -4.62% |
| Tradr 2X Long SMR Daily ETF (SMU) | |||
| ARKI | 22.30 | -1.93 | -7.98% |
| ARK DIET Q2 Buffer ETF (ARKI) | |||